BRAF inhibition with concomitant tumor treating fields for a multiply progressive pleomorphic xanthoastrocytoma

per Lukas, Rimas V, Merrell, Ryan T
Publicat a CNS Oncol (2018)

NT-15 STEREOTACTIC LASER THERMAL ABLATION OF RECURRENT POSTERIOR FOSSA METASTATIC LESION: DESCRIPTION OF NEW TECHNOLOGY FOR INFRATENTORIAL TUMORS REFRACTORY TO CONVENTIONAL THERAPI...

per Eliyas, Javed Khader, Bailes, Julian, Merrell, Ryan, O'Leary, Shaun
Publicat 2014

MNGI-03. PATIENT PARAMETERS ASSOCIATED WITH TUMOR GROWTH IN INCIDENTAL MENINGIOMA

per Kamson, David, Yuen, Carlen, Castillo-Saavedra, Laura, Wilmington, Andrew, Walker, Matthew, Merrell, Ryan
Publicat a Neuro Oncol (2018)

Multifocal and Multicentric Glioblastoma with Leptomeningeal Gliomatosis: A Case Report and Review of the Literature

per Shakur, Sophia F., Bit-Ivan, Esther, Watkin, William G., Merrell, Ryan T., Farhat, Hamad I.
Publicat 2013

Combined Open and Endoscopic Endonasal Skull Base Resection of a Rare Endometrial Carcinoma Metastasis

per Stamates, Melissa M., Lee, John M., Merrell, Ryan T., Shinners, Michael J., Wong, Ricky H.
Publicat a J Neurol Surg Rep (2018)

MNGI-03. ESTROGEN HORMONE REPLACEMENT THERAPY IN INCIDENTAL MENINGIOMA - A GROWTH RATE ANALYSIS

per Kamson, David, Yuen, Carlen, Castillo Saavedra, Laura, Jenkins Vogel, Tilley, Merrell, Ryan, Walker, Matthew
Publicat a Neuro Oncol (2019)

Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis

per Dresser, Laura, Yuen, Carlen Amy, Wilmington, Andrew, Walker, Matthew, Vogel, Tilley Jenkins, Merrell, Ryan T., Kamson, David Olayinka
Publicat a Sci Rep (2020)

Standardizing Care of Neuro-oncology Patients Using a Customized Electronic Medical Record Toolkit

per Merrell, Ryan T., Simon, Kelly Claire, Martinez, Nina, Vazquez, Rosa Maria, Hadsell, Bryce, Epshteyn, Alexander, Wilk, Gary, Frigerio, Roberta, Maraganore, Demetrius M.
Publicat a Mayo Clin Proc Innov Qual Outcomes (2021)

RT-08 PROTON THERAPY (PT) LARGE-VOLUME RE-IRRADIATION FOR RECURRENT GLIOMA: OVERALL SURVIVAL (OS) AND TOXICITY OUTCOMES

per Desai, Brijal, Rockne, Russell, Rademaker, Alfred, Raizer, Jeffrey, Paleologos, Nina, Merrell, Ryan, Grimm, Sean, Azeem, Syed, Hartsell, William, Sweeney, Patrick, Swanson, Kristin, Gondi, Vinai
Publicat a Neuro Oncol (2014)

PATH-29. MOLECULAR DETERMINANTS ASSOCIATED WITH RESPONSE AND RESISTANCE TO DEPATUXIZUMAB MAFODOTIN (ABT-414) IN PATIENTS WITH RECURRENT GLIOBLASTOMA

per Lassman, Andrew, Roberts-Rapp, Lisa, He, Lei, Lu, Xin, van den Bent, Martin, Papadopoulos, Kyriakos, Merrell, Ryan, Kumthekar, Priya, Reardon, David, Gomez, Erica, Fischer, JuDee, Jiang, Fang, Zha, Zheng, Bhathena, Anahita, Holen, Kyle, Ansell, Peter, Gan, Hui K, Scott, Andrew
Publicat a Neuro Oncol (2017)

ATCT-34 BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB PLUS VORINOSTAT VERSUS BEVACIZUMAB ALONE IN ADULTS WITH RECURRENT GLIOBLASTOMA

per Wu, Jing, Puduvalli, Vinay K., Yuan, Ying, Armstrong, Terri, Walker, Brenda, Upshaw, Charlene, Giglio, Pierre, Colman, Howard, Groves, Morris D., Raizer, Jeffrey, Walbert, Tobias, Tran, David, Avgeropoulos, Nicholas, Iwamoto, Fabio, Peereboom, David, Chamberlain, Marc, Merrell, Ryan, Paleologos, Nina, Fink, Karen, Gilbert, Mark R.
Publicat a Neuro Oncol (2015)

GENE-23. PREVIOUSLY IDENTIFIED COMMON GLIOMA RISK SNPs ARE ASSOCIATED WITH FAMILIAL GLIOMA

per Ostrom, Quinn, Armstrong, Georgina, Amos, Christopher, Bernstein, Jonine, Claus, Elizabeth, Eckel-Passow, Jeanette, Il’yasova, Dora, Johansen, Christoffer, Lachance, Daniel, Lai, Rose, Merrell, Ryan, Olson, Sara, Schildkraut, Joellen, Shete, Sanjay, Houlston, Richard, Jenkins, Robert, Wrensch, Margaret, Melin, Beatrice, Barnholtz-Sloan, Jill, Bondy, Melissa
Publicat a Neuro Oncol (2018)

ET-19 A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM)

per Gan, Hui K., Fichtel, Lisa, Lassman, Andrew B., Merrell, Ryan, van den Bent, Martin, Kumthekar, Priya, Scott, Andrew M., Pedersen, Michelle, Gomez, Erica, Fischer, JuDee, Ames, William, Xiong, Hao, Dudley, Matt, Munasinghe, Wijith, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle, Reardon, David A.
Publicat 2014

ATNT-01 ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)...

per Gan, Hui K., Kumthekar, Priya, Lassman, Andrew B., Merrell, Ryan, van den Bent, Martin, Papadopoulos, Kyriakos P., Scott, Andrew M., Gomez, Erica, Fischer, JuDee, Mandich, Helen, Xiong, Hao, Lee, Ho-Jin, Munasinghe, Wijith, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle, Lai, Rose, Reardon, David A.
Publicat a Neuro Oncol (2015)

ATNT-02 DETERMINANTS OF RESPONSES AND RESISTANCE TO ABT-414: RESULTS OF NEXT-GENERATION SEQUENCING

per Scott, Andrew M., Roberts-Rapp, Lisa, Gan, Hui K., Lu, Xin, Lassman, Andrew B., van den Bent, Martin, Papadopoulos, Kyriakos P., Merrell, Ryan, Kumthekar, Priya, Reardon, David A., Sokolova, Irina, Song, Minghao, Kular, Rupinder, Gomez, Erica, Fischer, JuDee, Bhathena, Anahita, Holen, Kyle, Lai, Rose, Ansell, Peter
Publicat a Neuro Oncol (2015)

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma

per Reardon, David A., Lassman, Andrew B., van den Bent, Martin, Kumthekar, Priya, Merrell, Ryan, Scott, Andrew M., Fichtel, Lisa, Sulman, Erik P., Gomez, Erica, Fischer, JuDee, Lee, Ho-Jin, Munasinghe, Wijith, Xiong, Hao, Mandich, Helen, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle D., Gan, Hui K.
Publicat a Neuro Oncol (2017)

ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS

per Puduvalli, Vinay, Wu, Jing, Yuan, Ying, Armstrong, Terri, Wu, Jimin, Giglio, Pierre, Xu, Jihong, Colman, Howard, Walbert, Tobias, Raizer, Jeffrey, Groves, Morris, Iwamoto, Fabio, Tran, David, Avgeropoulos, Nicholas, Paleologos, Nina, Fink, Karen, Peereboom, David, Chamberlain, Marc, Merrell, Ryan, Penas-Prado, Marta, Yung, W K Alfred, Gilbert, Mark
Publicat a Neuro Oncol (2018)

ATCT-22 NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA

per Lee, Eudocia Q., Zhang, Peixin, Wen, Patrick Y., Gerstner, Elizabeth R., Reardon, David A., Aldape, Ken, de Groot, John F., Choe, Kevin S., Raizer, Jeffrey J., Kim, Lyndon J., Chmura, Steven J., Robins, H. Ian, Connelly, Jennifer, Battiste, James, Villano, John, Wagle, Naveed, Merrell, Ryan T., Wendland, Merideth, Mehta, Minesh P.
Publicat a Neuro Oncol (2015)

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma

per Puduvalli, Vinay K, Wu, Jing, Yuan, Ying, Armstrong, Terri S, Vera, Elizabeth, Wu, Jimin, Xu, Jihong, Giglio, Pierre, Colman, Howard, Walbert, Tobias, Raizer, Jeffrey, Groves, Morris D, Tran, David, Iwamoto, Fabio, Avgeropoulos, Nicholas, Paleologos, Nina, Fink, Karen, Peereboom, David, Chamberlain, Marc, Merrell, Ryan, Penas Prado, Marta, Yung, W K Alfred, Gilbert, Mark R
Publicat a Neuro Oncol (2020)

EPID-01 CHICKEN POX AND GLIOMA RISK: PRELIMINARY RESULTS FROM THE GLIOGENE INTERNATIONAL CASE-CONTROL STUDY

per Amirian, E. Susan, Scheurer, Michael, Armstrong, Georgina, Zhou, Renke, Lau, Ching, Claus, Elizabeth, Barnholtz-Sloan, Jill, Il'yasova, Dora, Schildkraut, Joellen, Ali-Osman, Francis, Sadetzki, Siegal, Johansen, Christoffer, Houlston, Richard, Jenkins, Robert, Lachance, Daniel, Olson, Sara, Bernstein, Jonine, Merrell, Ryan, Wrensch, Margaret, Davis, Faith, Lai, Rose, Shete, Sanjay, Amos, Christopher I., Melin, Beatrice S., Bondy, Melissa
Publicat a Neuro Oncol (2015)